ArticlePloS one2025
Encapsulation of anticancer drugs into carbon nanotubes: Heuristic algorithm approach and mathematical model.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Versatile metal-phenolic network structure (MPNs) as advanced delivery platforms for bioactive compounds: The design principles, foundations, applications, and future perspectives.Materials today. Bio · 2026Review
- Smart Nanoformulations for Oncology: A Review on Overcoming Biological Barriers with Active Targeting, Stimuli-Responsive, and Controlled Release for Effective Drug Delivery.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research combines mathematical derivation and optimization techniques to investigate the non-covalent encapsulation of chemotherapy drugs (fluorouracil, proflavine, methylene blue, and doxorubicin) within carbon nanotubes, aiming to improve targeted drug delivery in cancer therapy. We derive analytical expression for the interaction energy between an atom and an infinite cylinder, and utilize the U-NSGA-III algorithm to optimize the system's energy by varying molecular positions and tube radius. Optimal tube radii for single- and dual-drug encapsulations are determined. Fixing the tube radius at 10 Å and varying the number of drug molecules, we observe that the shortest distance from the drug's center of mass to the tube wall is independent of the number of encapsulated molecules, depending only on the drug type. Moreover, equilibrium configurations exhibit two primary patterns, clustering near the tube wall or dispersion around the circumference, suggesting potential control mechanisms for drug release kinetics. This hybrid approach, integrating analytical and computational methods, significantly reduces computational cost, providing a foundation for studying drug-nanocarrier interactions, ultimately accelerating the development of more effective and targeted cancer treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.